Cover
Cover | Sep. 28, 2023 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Sep. 28, 2023 |
Entity File Number | 001-40021 |
Entity Registrant Name | AEON Biopharma, Inc. |
Entity Central Index Key | 0001837607 |
Entity Tax Identification Number | 85-3940478 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 5 Park Plaza, |
Entity Address, Address Line Two | Suite 1750 |
Entity Address, City or Town | Irvine |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92614 |
City Area Code | 949 |
Local Phone Number | 354-6499 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Common Stock [Member] | |
Title of 12(b) Security | Class A common stock, $0.0001 par value per share |
Trading Symbol | AEON |
Security Exchange Name | NYSE |
Warrant [Member] | |
Title of 12(b) Security | Warrants to purchase Class A common stock |
Trading Symbol | AEON WS |
Security Exchange Name | NYSE |